Physician profile
Gil Aronson
NPI 1881666907
$1,240.39
in general payments reported to CMS, 2019-2025
17 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $258 · 2021: $428 · 2022: $91.37 · 2023: $33.86 · 2024: $22.64 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $188.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $253.12 | 2019-2023 | Lo Loestrin Fe |
| Avion Pharmaceuticals | $169.43 | 2019-2022 | |
| Hologic Sales and Service, LLC | $137.59 | 2021 | |
| Exeltis, USA INC. | $89.19 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $75.53 | 2021-2022 | |
| Roche Diagnostics Corporation | $71.97 | 2019-2020 | |
| Pfizer INC. | $71.01 | 2023-2025 | |
| Therapeuticsmd, INC. | $59.13 | 2020-2021 | |
| Evofem Biosciences, INC. | $58.77 | 2021-2025 | Phexxi, Solosec, Phexx |
| Coopersurgical, INC. | $52.37 | 2020-2022 | |
| Vertical Pharmaceuticals, LLC | $46.29 | 2020 | |
| Ge Healthcare | $39.50 | 2025 | |
| Allergan, INC. | $37.45 | 2019 | |
| Duchesnay USA Incorporated | $24.83 | 2019 | |
| Millicent US INC | $21.46 | 2025 | Intrarosa |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $17.24 | 2021 | |
| Amag Pharmaceuticals, INC. | $15.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gil Aronson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.